Advertisement

Topics

Selvita and The Leukemia Lymphoma Society Announce Partnership to Advance SEL120 Into Phase I ...

03:04 EDT 8 Aug 2017 | BioMedReports - Blog

SEL120 is an ATP-competitive and selective inhibitor of CDK8 and a closely related serine kinase, CDK19. CDK8 is a part of a multi-protein complex that

Read more...

Original Article: Selvita and The Leukemia Lymphoma Society Announce Partnership to Advance SEL120 Into Phase I ...

NEXT ARTICLE

More From BioPortfolio on "Selvita and The Leukemia Lymphoma Society Announce Partnership to Advance SEL120 Into Phase I ..."

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...